Don't know but I do know there is absolutely no reason to sell now. In a fair world the stock should open over $60 but the world is not fair. Who knows where the crooks will place their bids and asks. They have total control of the float.
Hedging with puts is too expensive. Sell if you can't handle the risk. Besides, long term everything will be fine regardless. We are going to get approval eventually, even if god forbid we get a crl right now. The drug is effective and will get approved. BB warning or no it's going to make a ton of money.
So as long as you are committed to hold the stock for another year, anything that happens in the next few days is really no big deal. ACAD is a huge winner long term.
that kind of variation could easily be a coincidence when you consider how the people died and the frailty of patients suffering Parkinson's.
That was the downside of not running more trials, but the FDA said we were good to go with the data so we stopped the trials and submitted the NDA.
I agree with you. I don't see any safety issues at all. The deaths were all completely unrelated to Pima. Not sure why that suddenly changed. Perhaps it's all CYA by the FDA. It is really odd the way the narrative has changed recently. I remember a year ago people calling it safer than aspirin. Not sure what to think. But don't be surprised if the label is completely clean.
You're right, I am not paying attention to bloggers making up fantasy stories so they can get out of bad trade.
ADCOM panelists didn't understand the questions? LOL What are they from Miami-Dade? Give me a break.
Bipolar. It's great one day and terrible the next. I think in the end, they don't get approval, and those trading this stock are getting played big time. Stay away. JMHO
2 trading days left until we get the news. Unless there is a delay? Is the FDA ever late on these decisions? There was a lot of talk about early decisions before. None about late ones.
Money flow into the market has been horrible for a year. And biotech is the redheaded stepchild.
Yes it is a problem because the banks can put this stock wherever they want it. So it's not going to move until they want it to. Regardless of the facts.